Related Experiment Video
Updated: Oct 18, 2026

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
Proteasome-mediated degradation of transcriptional activators correlates with activation domain potency in vivo
E Molinari1, M Gilman, S Natesan
1ARIAD Gene Therapeutics Inc., 26 Landsdowne Street, Cambridge, MA 02139, USA.
Abstract:
We show that the intracellular concentration of transcriptional activator proteins is regulated by the proteasome-mediated protein degradation pathway. The rate of degradation of activators by proteasomes correlates with activation domain potency in vivo. Mutations either in the activation domain residues involved in target protein interaction or in the DNA-binding domain residues essential for DNA binding abolish the transcriptional activation function in vivo and render the activator resistant to degradation by proteasomes. Finally, using a rapamycin-regulated gene expression system, we show that recruiting activation domains to DNA-bound receptor proteins greatly enhanced the rate of degradation of reconstituted activators. These observations suggest that in mammalian cells efficient recruitment of activator-target protein complexes to the promoter means that they are subjected to rapid degradation by proteasomes. We propose that proteasome-mediated control of the intracellular levels of transcriptional activators could play an important role in the regulation of gene expression.
Insights
Transcriptional activator protein levels are controlled by proteasome degradation. Potent activators and those recruited to DNA are rapidly degraded, suggesting proteasomal control is key for gene regulation.
Area of Science:
- Molecular Biology
- Gene Regulation
- Protein Degradation
Background:
- Transcriptional activators are crucial for gene expression.
- Their intracellular levels must be tightly regulated.
- The role of protein degradation in this regulation is not fully understood.
Purpose of the Study:
- To investigate the role of the proteasome-mediated protein degradation pathway in regulating transcriptional activator protein concentration.
- To determine the relationship between activator potency and degradation rate.
- To elucidate the impact of mutations and recruitment on activator degradation.
Main Methods:
- Studying proteasome-mediated degradation of transcriptional activators in vivo.
- Assessing the correlation between activation domain potency and degradation rate.
- Analyzing the effects of mutations in activation and DNA-binding domains on function and degradation.
- Employing a rapamycin-regulated gene expression system to study activator recruitment.
Main Results:
- Intracellular concentrations of transcriptional activators are regulated by proteasome-mediated degradation.
- The degradation rate of activators correlates with activation domain potency.
- Mutations affecting target protein interaction or DNA binding abolish function and confer resistance to degradation.
- Recruiting activation domains to DNA-bound receptors significantly enhances degradation rates.
Conclusions:
- Proteasome-mediated degradation is a key mechanism controlling transcriptional activator levels in mammalian cells.
- Activation domain potency and recruitment to DNA influence degradation rates.
- This pathway likely plays a significant role in the precise regulation of gene expression.
Related Concept Videos
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
RNA Polymerase II Accessory Proteins
Co-activators and Co-repressors
Co-activators and Co-repressors
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Prokaryotic Transcriptional Activators and Repressors
Transcription of prokaryotic...

